Ash Access Technology, Inc. is a privately held company dedicated to advancing the care of patients requiring vascular access and infection control in both the acute and chronic health care environments. Our core technologies are specifically targeting the primary complications a patient on vascular access likely will experience - a rapidly escalating incidence of deadly infections (CRBSI) and poor patency (blood flow rates).

If you are a current shareholder of Ash Access Technology Inc. you may view additional corporate updates and information. (Temporarily disabled.)